Search
for
Sort by
Research 811–840 of 1000+
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Advanced medical treatments for hair loss
- Diagnosis of polycystic ovaries syndrome: establishment of reference values of nine hormones on Maglumi X- 8
- A Complex Clinical Situation in Polycystic Ovary Syndrome: HAIR‐AN Syndrome ‘‘Case Report’’
- Spironolactone
- The Effects of Single Testosterone Administration and Stress Induction on Steroid Hormone Levels in Hair
- A scientometric study on research trends and characteristics of discoid lupus erythematosus
- Efficacy and Adverse Effects of Corticosteroid Pulse Therapy in Alopecia Areata
- LB999 Role of transcription factor Ovol2 in skin epithelial regeneration and repair
- Efficacy and tolerability of azathioprine for neuromyelitis optica spectrum disorder: A systematic review and meta-analysis
- Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage
- Short- and mid-term outcomes of multisystem inflammatory syndrome in children: a longitudinal prospective single-center cohort study
- Performance and Tolerance of a Protocol for Idiopathic Chronic Greasy Seborrhea in 18 Dogs Using a Shampoo and Mousse Containing Plant Extracts
- Acne Syndromes and Mosaicism
- Clinical characteristics, subtype classification, and prognostic factors of ophiasis: A retrospective study of 150 patients with therapeutic implications
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Microarray Gene Expression Analysis of Lesional Skin in Canine Pemphigus Foliaceus
- The JAK/STAT signaling pathway: from bench to clinic
- Corticotropin-releasing hormone: An autocrine hormone that promotes lipogenesis in human sebocytes
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Intracrine androgen biosynthesis, metabolism and action revisited
- Recurrent implantation failure: A comprehensive summary from etiology to treatment
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- FGF Family: From Drug Development to Clinical Application
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review